check_circleStudy Completed

Diagnostic imaging

Bayer Identifier:

Trial_87054

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA in the whole body

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

5 - 82 Years
  • -

  • -

Trial summary

Enrollment Goal
388
Trial Dates
May 1987 - December 1989
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open clinical study in MRI (Magnetic Resonance Imaging) to demonstrate the tolerance and efficacy of Gd-DTPA (Gadolinium Diethylene triamine penta acetic Acid) in the whole body
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.